RT302（Regel Therapeutics）

N/A

Report date: 2024/09/06 16:27:28

Base Information

Drug NameRT302（Regel Therapeutics）
Drug Alias NameRT-302RT302
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene expression modulators
TargetsUpdating
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRegel Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesRegel Therapeutics
Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A